Aerolyn Biotech Launches Commercial-Grade Idebenone for Pharmaceutical, Cosmetics and Nutraceutical Applications
订阅
Shanghai Aerolyn Biotech Advances Idebenone Commercialization: Pharmaceutical-Grade Supply Now Available, Delivering Sup
Shanghai Aerolyn Biotech Advances Idebenone Commercialization: Pharmaceutical-Grade Supply Now Available, Delivering Superior Purity & Performance
SHANGHAI, CHINA – March 5, 2026 – Shanghai Aerolyn Biotech Co., Ltd. (Aerolyn Biotech) announced today the successful development and full commercial availability of its pharmaceutical-grade idebenone, a high-value synthetic ubiquinone analog widely valued for its potent mitochondrial support, antioxidant activity, and neuroprotective benefits. Engineered to outperform conventional market offerings in purity, consistency, and compliance, Aerolyn’s idebenone is positioned to serve as a reliable, high-quality raw material source for global cosmetics, dietary supplement, and pharmaceutical manufacturers.Idebenone, a well-characterized analog of coenzyme Q10, has gained broad adoption across multiple industries: in pharmaceuticals, it supports cognitive function and addresses neurological impairment linked to cerebrovascular injury; in cosmetics, it delivers powerful anti-aging, free-radical-scavenging, and skin-repairing effects to reduce dullness and combat oxidative skin damage; in nutraceuticals, it supports mitochondrial health, reduces fatigue, and provides targeted nutritional support for aging populations and high-intellectual-output workers.Aerolyn Biotech’s pharmaceutical-grade idebenone stands apart from commodity-grade alternatives through rigorous process optimization and strict quality control. The product meets and exceeds prevailing industry and pharmacopeial standards, with enhanced purity profiles, controlled impurity levels, and improved batch-to-batch consistency that enable formulators to develop safer, more effective finished products with greater reliability. This commercial-scale production milestone addresses growing market demand for premium idebenone supply, particularly in regulated cosmetics and nutraceutical segments.“We are proud to bring our high-purity, pharmaceutical-grade idebenone to full commercial scale, reinforcing Aerolyn Biotech’s commitment to advancing high-quality raw material solutions for health, beauty, and pharma sectors,” said a representative of Aerolyn Biotech. “By elevating purity and performance beyond current market standards, we enable our partners to create differentiated, compliance-ready finished products that resonate with today’s discerning consumers. We are actively supporting rapid, scalable supply to cosmetics and nutraceutical enterprises worldwide, with flexible order volumes to meet diverse production needs.”Beyond current commercial supply for cosmetic and nutraceutical applications, Aerolyn Biotech also outlined its long-term strategic roadmap: the company plans to pursue regulatory registration and certification for its idebenone to expand its presence in regulated pharmaceutical markets, further solidifying its position as a trusted, integrated supplier across the idebenone value chain.For partnership, sample requests, or commercial supply inquiries, please contact Shanghai Aerolyn Biotech directly to discuss customized raw material solutions and supply chain support.
阅读全文
请先 登录后发表评论 ~